A Randomized Trial of Tbo-Filgrastim Versus Filgrastim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma

Authors
Category Primary study
JournalBlood
Year 2015
This article has no abstract
Epistemonikos ID: 27f110338c422ca3e8345bc5cf28fbc838c72462
First added on: Feb 19, 2025